ReviewHuman vaccines & immunotherapeutics2017

Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.

Bernhard ReschPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.